David Weill, Director at TransMedics Group, Inc. (TMDX), sold 1,464 shares at $123.88 ($181K) on 2025-05-23, disclosed to the SEC on 2025-05-23.
Open-market sale of $181k TMDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $123.88 | 732 | $91K | 50.0% |
| 2 | $123.88 | 732 | $91K | 50.0% |
| Total | $123.88 avg | 1,464 | $181K | 100% |
| Filing → |
| TMDX | SELL | 2025-12-05 | $1.4M | — | Filing → |
| TMDX | SELL | 2024-05-31 | $338K | — | Filing → |
| TMDX | SELL | 2024-05-14 | $325K | — | Filing → |